南印度新生儿危重先天性心脏病:前瞻性注册研究结局
该前瞻性医院注册研究在印度喀拉拉邦47家医院纳入1474例≤28天先天性心脏病新生儿,其中418例(27%)为危重先心病,1月龄死亡率22%。脉搏血氧筛查识别72%危重病例,仅8%导管依赖病变新生儿转运时使用前列腺素,术前死亡占全部死亡的86%。
要点
- 危重先心病占注册病例27%,1月龄死亡22%。
- 脉搏血氧筛查识别72%危重先心病,产前诊断仅14%。
- 仅8%导管依赖病变新生儿转运时使用前列腺素。
核心结论
- 系统筛查尤其是脉搏血氧筛查有助于早期识别和及时管理相当比例危重先心病新生儿,但前列腺素使用率低等卫生系统挑战需克服以减少术前死亡。
研究设计与样本
- 先天性心脏病新生儿注册研究(CHRONIK)为前瞻性医院注册研究,纳入印度喀拉拉邦47家医院2018年6月1日至2019年5月31日≤28天新生儿,排除高概率自发闭合的小分流。
主要发现
- 共识别1474例先心病新生儿,418例(27%)为危重先心病,其中22%在1月龄死亡。
- 危重先心病诊断中位年龄为1(0-22)天。
- 脉搏血氧筛查识别72%危重先心病,14%产前诊断。
- 仅8%导管依赖病变新生儿转运时使用前列腺素。
- 术前死亡占全部死亡的86%;多变量分析仅出生体重(OR 2.7;95%CI 2.1-6.5;p<0.0005)和导管依赖体循环(OR 6.43;95%CI 5-21.8;p<0.0005)预测死亡。
关键数值与推荐
- 危重先心病占27%,1月龄死亡率22%,脉搏血氧筛查识别率72%,产前诊断率14%,前列腺素转运使用率8%,术前死亡占86%。
临床怎么用
- 对新生儿开展脉搏血氧筛查以早期识别危重先心病,并提高导管依赖病变新生儿转运期间前列腺素的使用以降低术前死亡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Congenital heart disease (CHD) is now a leading contributor of infant and neonatal mortality in many low/middle-income countries including India. We established a prospective neonatal heart disease registry in Kerala to understand presentation of CHD, proportion of newborns with critical defects who receive timely intervention, outcomes at 1 month, predictors of mortality and barriers to timely management. METHODS: The congenital heart disease registry for newborns (≤28 days) in Kerala (CHRONIK) was a prospective hospital-based registry involving 47 hospitals from 1 June 2018 to 31 May 2019. All CHDs, except small shunts with a high likelihood of spontaneous closure, were included. Data on demographics, complete diagnosis, details of antenatal and postnatal screening, mode of transport and distance travelled and need for surgical or percutaneous interventions and survival were collected. RESULTS: Of the 1474 neonates with CHD identified, 418 (27%) had critical CHD, 22% of whom died at 1 month. Median age at diagnosis of critical CHD was 1 (0-22) day. Pulse oximeter screening identified 72% of critical CHD and 14% were diagnosed prenatally. Only 8% of neonates with duct-dependent lesions were transported on prostaglandin. Preoperative mortality accounted for 86% all deaths. On multivariable analysis, only birth weight (OR 2.7; 95% CI 2.1 to 6.5; p<0.0005) and duct-dependent systemic circulation (OR 6.43; 95% CI 5 to 21.8, p<0.0005) were predictive of mortality. CONCLUSIONS: While systematic screening, especially pulse oximetry screening, enabled early identification and prompt management of a significant proportion of neonates with critical CHD, important health system challenges like low use of prostaglandin need to be overcome to minimise preoperative mortality.
引用
- Sasikumar D, Prabhu MA, Kurup R, et al. Outcomes of neonatal critical congenital heart disease: results of a prospective registry-based study from South India. Arch Dis Child. 2023. PMID: 37328195. doi:10.1136/archdischild-2023-325471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。